Osteomodulin modulates the inflammatory responses via the interleukin-1 receptor 1/nuclear factor-κB signaling pathway in dental pulpitis

Abstract

Pulpitis is a common infective oral disease in clinical situations. The regulatory mechanisms of immune defense in pulpitis are still being investigated. Osteomodulin (OMD) is a small leucine-rich proteoglycan family member distributed in bones and teeth. It is a bioactive protein that promotes osteogenesis and suppresses the apoptosis of human dental pulp stem cells (hDPSCs). In this study, the role of OMD in pulpitis and the OMD-induced regulatory mechanism were investigated. The OMD expression in normal and inflamed human pulp tissues was detected via immunofluorescence staining. Intriguingly, the OMD expression decreased in the inflammatory infiltration area of pulpitis specimens. The cellular experiments demonstrated that recombined human OMD could resist the detrimental effects of lipopolysaccharide (LPS)-induced inflammation. A conditional Omd knockout mouse model with pulpal inflammation was established. LPS-induced inflammatory impairment significantly increased in conditional Omd knockout mice, whereas OMD administration exhibited a protective effect against pulpitis. Mechanistically, the transcriptome alterations of OMD overexpression showed significant enrichment in the nuclear factor-κB (NF-κB) signaling pathway. Interleukin-1 receptor 1 (IL1R1), a vital membrane receptor activating the NF-κB pathway, was significantly downregulated in OMD-overexpressing hDPSCs. Additionally, the interaction between OMD and IL1R1 was verified using co-immunoprecipitation and molecular docking. In vivo, excessive pulpal inflammation in Omd-deficient mice was rescued using an IL1R antagonist. Overall, OMD played a protective role in the inflammatory response via the IL1R1/NF-κB signaling pathway. OMD may optimize the immunomodulatory functions of hDPSCs and can be used for regenerative endodontics.

References

[1] SantosJM, PereiraJF, MarquesA, SequeiraDB, FriedmanS. Vital pulp therapy in permanent mature posterior teeth with symptomatic irreversible pulpitis: a systematic review of treatment outcomes. Medicina (Kaunas), 2021, 57: 573.

[2] YoshidaS, et al. . Semaphorin 3A induces odontoblastic phenotype in dental pulp stem cells. J. Dent. Res., 2016, 95: 1282-1290.

[3] FinethyR, CoersJ. Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis. FEMS Microbiol. Rev., 2016, 40: 875-893.

[4] HongH, et al. . The pluripotent factor OCT4A enhances the self-renewal of human dental pulp stem cells by targeting lncRNA FTX in an LPS-induced inflammatory microenvironment. Stem Cell Res. Ther., 2023, 14: 109.

[5] ZhangX, et al. . Cell-derived micro-environment helps dental pulp stem cells promote dental pulp regeneration. Cell Prolif., 2017, 50. e12361

[6] GoldbergM, et al. . Inflammatory and immunological aspects of dental pulp repair. Pharm. Res., 2008, 58: 137-147.

[7] CookeJP. Inflammation and its role in regeneration and repair. Circ. Res., 2019, 124: 1166-1168.

[8] AzaryanE, et al. . Effect of HM-Exos on the migration and inflammatory response of LPS-exposed dental pulp stem cells. BMC Oral Health, 2023, 23. 95

[9] LinW, et al. . Osteomodulin positively regulates osteogenesis through interaction with BMP2. Cell Death Dis., 2021, 12. 147

[10] ElsalhyM, AziziehF, RaghupathyR. Cytokines as diagnostic markers of pulpal inflammation. Int. Endod. J., 2013, 46: 573-580.

[11] ChangMC, et al. . Regulation of vascular cell adhesion molecule-1 in dental pulp cells by interleukin-1β: the role of prostanoids. J. Endod., 2012, 38: 774-779.

[12] YuanH, et al. . MicroRNA let-7c-5p suppressed lipopolysaccharide-induced dental pulp inflammation by inhibiting dentin matrix protein-1-mediated nuclear factor kappa B (NF-κB) pathway in vitro and in vivo. Med. Sci. Monit., 2018, 24: 6656-6665.

[13] LiangC, LiW, HuangQ, WenQ. CircFKBP5 suppresses apoptosis and inflammation and promotes osteogenic differentiation. Int. Dent. J., 2023, 73: 377-386.

[14] AlfordAI, HankensonKD. Matricellular proteins. Extracellular modulators of bone development, remodeling, and regeneration. Bone, 2006, 38: 749-757.

[15] WendelM, SommarinY, HeinegårdD. Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine bone. J. Cell Biol., 1998, 141: 839-847.

[16] SommarinY, WendelM, ShenZ, HellmanU, HeinegârdD. Osteoadherin, a cell-binding keratan sulfate proteoglycan in bone, belongs to the family of leucine-rich repeat proteins of the extracellular matrix. J. Biol. Chem., 1998, 273: 16723-16729.

[17] BuchailleR, CoubleML, MagloireH, BleicherF. Expression of the small leucine-rich proteoglycan osteoadherin/osteomodulin in human dental pulp and developing rat teeth. Bone, 2000, 27: 265-270.

[18] NikdinH, OlssonML, HultenbyK, SugarsRV. Osteoadherin accumulates in the predentin towards the mineralization front in the developing tooth. PLoS ONE, 2012, 7: e31525.

[19] TashimaT, et al. . Molecular basis for governing the morphology of type-I collagen fibrils by Osteomodulin. Commun. Biol., 2018, 1: 33.

[20] PeterssonU, HultenbyK, WendelM. Identification, distribution and expression of osteoadherin during tooth formation. Eur. J. Oral Sci., 2003, 111: 128-136.

[21] LinW, et al. . The role of osteomodulin on osteo/odontogenic differentiation in human dental pulp stem cells. BMC Oral Health, 2019, 19. 22

[22] DongT, et al. . Osteomodulin protects dental pulp stem cells from cisplatin-induced apoptosis in vitro. Stem Cell Rev. Rep., 2023, 19: 188-200.

[23] NinomiyaK, et al. . Osteoclastic activity induces osteomodulin expression in osteoblasts. Biochem. Biophys. Res. Commun., 2007, 362: 460-466.

[24] LyonSM, et al. . Whole-proteome analysis of human craniosynostotic tissue suggests a link between inflammatory signaling and osteoclast activation in human cranial suture patency. Plast. Reconstr. Surg., 2018, 141: 250e-260e.

[25] JuchtmansN, et al. . Distinct dysregulation of the small leucine-rich repeat protein family in osteoarthritic acetabular labrum compared to articular cartilage. Arthritis Rheumatol., 2015, 67: 435-441.

[26] HapponenKE, SjöbergAP, MörgelinM, HeinegårdD, BlomAM. Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix. J. Immunol., 2009, 182: 1518-1525.

[27] RanS, et al. . Enterococcus Faecalis activates NLRP3 inflammasomes leading to increased interleukin-1 beta secretion and pyroptosis of THP-1 macrophages. Microb. Pathog., 2021, 154: 104761.

[28] LvK, WangG, ShenC, ZhangX, YaoH. Role and mechanism of the nod-like receptor family pyrin domain-containing 3 inflammasome in oral disease. Arch. Oral Biol., 2019, 97: 1-11.

[29] YazalT, et al. . Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis. Biomed. Pharmacother., 2023, 167: 115619.

[30] FranchiL, EigenbrodT, Muñoz-PlanilloR, NuñezG. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol., 2009, 10: 241-247.

[31] GronthosS, MankaniM, BrahimJ, RobeyPG, ShiS. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl Acad. Sci. USA, 2000, 97: 13625-13630.

[32] KishenA, HusseinH. Bioactive molecule carrier systems in endodontics. Expert Opin. Drug Deliv., 2020, 17: 1093-1112.

[33] RoedigH, NastaseMV, WygreckaM, SchaeferL. Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy. FEBS J., 2019, 286: 2965-2979.

[34] MorethK, IozzoRV, SchaeferL. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle, 2012, 11: 2084-2091.

[35] BarretoG, et al. . Lumican is upregulated in osteoarthritis and contributes to TLR4-induced pro-inflammatory activation of cartilage degradation and macrophage polarization. Osteoarthr. Cartil., 2020, 28: 92-101.

[36] YuanX, HuaX, WilhelmusKR. Expression of small leucine-rich proteoglycans during experimental fungal keratitis. Cornea, 2010, 29: 674-679.

[37] SanchezC, et al. . Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: a pilot study. PLoS ONE, 2018, 13. e0194591

[38] KalchishkovaN, FürstCM, HeinegårdD, BlomAM. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J. Biol. Chem., 2011, 286: 27915-27926.

[39] AroraS, et al. . Potential application of immunotherapy for modulation of pulp inflammation: opportunities for vital pulp treatment. Int. Endod. J., 2021, 54: 1263-1274.

[40] ZhaoF, BaiY, XiangX, PangX. The role of fibromodulin in inflammatory responses and diseases associated with inflammation. Front. Immunol., 2023, 14: 1191787.

[41] FuJ, WuH. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu. Rev. Immunol., 2023, 41: 301-316.

[42] BabelovaA, et al. . Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J. Biol. Chem., 2009, 284: 24035-24048.

[43] BakhshA, MoyesD, ProctorG, MannocciF, NiaziSA. The impact of apical periodontitis, non-surgical root canal retreatment and periapical surgery on serum inflammatory biomarkers. Int. Endod. J., 2022, 55: 923-937.

[44] HasanA, et al. . Expression of toll-like receptor 2, dectin-1, and osteopontin in murine model of pulpitis. Clin. Oral Investig., 2023, 27: 1177-1192.

[45] HeY, et al. . Pulpal tissue inflammatory reactions after experimental pulpal exposure in mice. J. Endod., 2017, 43: 90-95.

[46] MinicS, et al. . Evaluation of pulp repair after biodentine(TM) full pulpotomy in a rat molar model of pulpitis. Biomedicines, 2021, 9: 784.

[47] ChungM, LeeS, KimS, KimE. Inflammatory response and odontogenic differentiation of inflamed dental pulp treated with different pulp capping materials: an in vivo study. Int. Endod. J., 2023, 56: 1118-1128.

[48] Abd-ElmeguidA, et al. . Osteocalcin expression in pulp inflammation. J. Endod., 2013, 39: 865-872.

[49] ChenZ, et al. . IL-1R/TLR2 through MyD88 divergently modulates osteoclastogenesis through regulation of nuclear factor of activated T cells c1 (NFATc1) and B lymphocyte-induced maturation protein-1 (Blimp1). J. Biol. Chem., 2015, 290: 30163-30174.

[50] VerstrepenL, et al. . TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell. Mol. Life Sci., 2008, 65: 2964-2978.

[51] ZappiaJ, et al. . Osteomodulin downregulation is associated with osteoarthritis development. Bone Res., 2023, 11: 49.

[52] NamOH, et al. . Ginsenoside Rb1 alleviates lipopolysaccharide-induced inflammation in human dental pulp cells via the PI3K/Akt, NF-κB, and MAPK signalling pathways. Int. Endod. J., 2024, 57: 759-768.

[53] ReinerA, YekutieliD, BenjaminiY. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics, 2003, 19: 368-375.

[54] AbramsonJ, et al. . Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 2024, 630: 493-500.

[55] AnandakrishnanR, AguilarB, OnufrievAV. H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res., 2012, 40: W537-W541.

[56] YanY, ZhangD, ZhouP, LiB, HuangSY. HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res., 2017, 45: W365-w373.

[57] FengLJ, et al. . Wnt5a deficiency in osteocalcin-expressing cells could not alleviate the osteoarthritic phenotype in a mouse model of post-traumatic osteoarthritis. Iran. J. Basic Med. Sci., 2024, 27: 671-677

[58] RichertR, et al. . A critical analysis of research methods and experimental models to study pulpitis. Int. Endod. J., 2022, 1: 14-36.

[59] ChungMK, LeeJ, DuraesG, RoJY. Lipopolysaccharide-induced pulpitis up-regulates TRPV1 in trigeminal ganglia. J. Dent. Res., 2011, 90: 1103-1107.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82071104)

Shanghai Hospital Development Center (SHDC)(SHDC12022120)

Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission)(23XD1434200/22Y21901000)

RIGHTS & PERMISSIONS

The Author(s)